Invention Grant
- Patent Title: Tumor necrosis factor 1B (TNF-1B) mutants and methods of use thereof to screen for candidate therapeutic compounds
-
Application No.: US15945887Application Date: 2018-04-05
-
Publication No.: US10717776B2Publication Date: 2020-07-21
- Inventor: Steven C. Almo , Sarah Garrett-Thomson , Ron Seidel
- Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE
- Applicant Address: US NY Bronx
- Assignee: Albert Einstein College of Medicine
- Current Assignee: Albert Einstein College of Medicine
- Current Assignee Address: US NY Bronx
- Agency: Perkins Coie LLP
- Main IPC: C07K14/705
- IPC: C07K14/705 ; G01N33/68 ; C07K14/715 ; G01N33/50 ; A61K38/00
Abstract:
Disclosed are tumor necrosis factor receptor 1B (TNFR-1B) signaling targets and TNFR-1B mutants and their uses for treatment of diseases and disorders.
Public/Granted literature
- US20180273604A1 THERAPEUTIC TNFR-1B TARGETS AND USES THEREOF Public/Granted day:2018-09-27
Information query
